XERS Stock Summary and Trading Ideas (Xeris Biopharma Holdings | NASDAQ:XERS)

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

What symbol and exchange does Xeris Biopharma Holdings shares trade?

Xeris Biopharma Holdings trades on the NASDAQ stock market under the symbol XERS.

What is Xeris Biopharma Holdings stock price doing today?

As of September 25, 2026, XERS stock price climbed to $9.10 with 1,442,906 million shares trading.

What is Xeris Biopharma Holdings's Beta?

XERS has a beta of 1.50, meaning it tends to be more sensitive to market movements. XERS has a correlation of 0.13 to the broad based SPY ETF.

How much is Xeris Biopharma Holdings worth?

XERS has a market cap of $1.66 billion. This is considered a Small Cap stock.

How much money does Xeris Biopharma Holdings make?

Last quarter Xeris Biopharma Holdings reported $92 million in Revenue and $.00 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.01.

What is the highest and lowest price Xeris Biopharma Holdings traded in the last 3 year period?

In the last 3 years, XERS traded as high as $10.08 and as low as $1.46.

What are the top ETFs holding Xeris Biopharma Holdings?

The top ETF exchange traded funds that XERS belongs to (by Net Assets): VTI, IWM, VXF, IWO, XPH.

Is Xeris Biopharma Holdings (XERS) a good investment?

XERS has underperformed the market in the last year with a return of +15.9%, while SPY returned +18.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XERS shares. However, XERS has outperformed the market in the last 3 month and 2 week periods, returning +23.0% and +22.1%, while SPY returned +5.3% and +1.2%, respectively. This indicates XERS has been having a stronger performance recently.

What are the support and resistance levels for Xeris Biopharma Holdings (XERS)?

XERS support price is $8.64 and resistance is $9.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XERS shares will trade within this expected range on the day.